Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × ARX788 × Breast × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 6 INDUSTRY 4 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 9 Tamoxifen 9 Docetaxel 9 Capecitabine 9 Exercise 7 pyrotinib 6 Paclitaxel 6 Letrozole 6 Gemcitabine 6 Cyclophosphamide 6 Control Groups 6 Carboplatin 6 Vinorelbine 5 Indocyanine Green 5 pertuzumab 4 exemestane 4 Injections 4 Doxorubicin 4 Anastrozole 4 dalpiciclib 3 Standard of Care 3 Radiotherapy 3 Radiation 3 Mammography 3 Fulvestrant 3 Epirubicin 3 Drug Therapy 3 Cisplatin 3 Bevacizumab 3 ferumoxides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06663748 2024-10-29

ARX788 in HER2-positive Metastatic Breast Cancer Patients

Henan Cancer Hospital

Phase 2 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡